Unloxcyt Electrifies Skin Cancer Battle with 50% Response Rate

Ladies and gentlemen, hold onto your hats! Sun Pharma's Unloxcyt is electrifying the skin cancer world! At ASCO, they unveiled a staggering 50% response rate—with 27% of patients going full superhero! After 31 months, this treatment is proving to be a relentless warrior against laCSCC! Get ready, because hope is making a comeback in epic style!